Start with a phone call. Your doctor’s office has a triage line and a nurse will talk it through with you. They are genuinely good at this, they do it all day, and it costs nothing. Most practices have a phone line where a nurse takes calls about whether something needs to be seen, and how soon. It is often not advertised — you ring the main number and ask to speak to the triage nurse. There is no charge and you do not need an appointment to use it.
If it feels more serious than that, go to urgent care. You will usually be seen faster than at a hospital, and the care is good.
If it feels life-threatening, call 911 or go to the emergency room. Do not wait until you are sure.
Which one is yours to decide, not ours. But our advice is to assume it is worse than it looks and take the more cautious road. And trust your body — if it is telling you something is wrong, it is probably right. The best possible outcome of a trip to the emergency room is walking out saying well, that was a waste of an evening — but I feel a lot better knowing it is nothing serious.
Before you call, have these ready. They are what the nurse will ask, and the call goes better when you are not working them out on the phone.
You are not diagnosing yourself by having this ready. You are handing them the things they would otherwise spend the call extracting — and the decision stays entirely theirs.
Writing to the portal instead of calling? The same list works, in that order, in one message. Put the direction it is going and the immune-system line near the top — portal messages get read quickly, and those two change how the rest is read.
Tick the ones that are true right now. Then read the line underneath them — it is there, and not at the bottom of the page, because that is where you need it.
What we would do, as a friend rather than as your doctor. This is our opinion and we stand behind it. It is not medical advice and we are not examining you.
Dark urine with muscle pain is the combination to act on. It can mean muscle is breaking down and the debris is passing through the kidneys. There is one cheap blood test for it, called CK. Asking for it is reasonable and it is quick.
Do not stop a prescribed medicine on your own. Statins are prescribed for good reasons and stopping one has its own risks. This page is about getting the question asked, not about changing anything by yourself.
None of them ticked? Then nothing below this is an emergency, and you can read the rest at your own pace.
The short answer, before anything else.
None of this was ever a mystery. Every piece of it was known. Each part is managed every day without incident. What is not managed is the three of them at once.
→ where this is explained: The part that was never a mystery
CK is the test used to decide whether a statin is hurting your muscles — and muscle is what makes CK. If you have already lost a lot of muscle, there is less left to release it, so the number can look reassuring while the problem is real.
→ where this is explained: What is happening to you, in your own words
The same trap sits under the kidney number. Creatinine also comes from muscle, so the estimate of your kidney function assumes your muscle is average for your age and sex. If it is not, the estimate is not either.
→ where this is explained: What is happening to you, in your own words
The one thing to do next: Worth asking: “I have lost a lot of muscle. Does that change how my CK result should be read?” and “Should my kidney function be checked with cystatin C rather than creatinine alone?”
Everything below explains each of those, in whatever order suits you.
None of what follows is obscure. That statins can injure muscle has been on the label for as long as there have been statins. That muscle is lost with age, with illness, and with chemotherapy is ordinary knowledge. That kidneys clear drugs, and clear them more slowly when they are struggling, is first-year pharmacology.
Every piece was known. What was missing was anybody holding all three at once. That is the whole of it, and it is why this page exists.
Each circle on its own is managed every day without incident. The middle is where the instruments that are supposed to warn you quietly stop being able to.
This describes how the measurements behave. It is not a claim about any particular person, and it is not a reason to change anything on your own.
Pick whichever sounds like you. There is no wrong door and no right order. Each one feeds the next, and the last feeds the first.
What CK is. Creatine kinase is an enzyme that lives inside muscle cells. When muscle is damaged it leaks out into the blood, so a high level means muscle is breaking down. That much is straightforward and it is why the test gets ordered.
Here is the part that is not obvious. CK comes from muscle. So how much of it you can produce depends on how much muscle you have. Someone who has lost a large part of their muscle has lost a large part of their capacity to make CK — and their “normal” result may be coming from half the tissue it used to.
Three findings, and they point the same way:
So a CK in the normal range cannot, on its own, rule this out in someone who has lost substantial muscle. It is a real result. It just does not answer the question people think it answers.
GRADE A The three findings above are published and specific. The 2002 paper is named so you can look it up or hand it over.
muscle lost → less tissue making CK → CK reads “normal” → read as no damage → the search stops
“I have lost a lot of muscle. Does that change how my CK result should be read?”
This is a fair question and a specialist will recognise it immediately. It is not a challenge — it is asking for the number to be read in context.
How the usual kidney number is worked out. The common test, eGFR, is calculated from creatinine in your blood. Creatinine is a waste product of muscle. Your muscles make it at a steady rate and your kidneys clear it, so if it piles up, the kidneys are not clearing it well.
What happens when muscle is lost. Less muscle makes less creatinine. Less creatinine in the blood reads as better kidney function — even when the kidney has not improved at all, and even when it has got worse. The number flatters the organ.
And this is where it stops being an abstraction. Drug doses are calculated from that number. A kidney figure that is too optimistic produces doses that are too high, for every drug cleared by the kidney — including, when it applies, the one that damaged the muscle in the first place.
GRADE A That creatinine-based eGFR overestimates kidney function when muscle mass is low is established and uncontroversial.
GRADE B The full loop as this page describes it — damage, to lost muscle, to a flattering number, to doses set from it — is this project’s own reading, assembled from those established parts. Good enough to raise; we are not claiming it as a described syndrome.
muscle lost → less creatinine made → eGFR looks better than the kidney is → doses calculated from it → more drug than intended
“My muscle mass has dropped a lot. Should my kidney function be checked with cystatin C rather than creatinine alone?”
Cystatin C is a second way of measuring the same thing that does not depend on muscle. You do not need to know the name to ask the question — but it is here if you want it.
Weight is a total, and totals hide trades. Muscle can be lost and fat gained at the same time, and the scale will sit exactly where it always did while your body composition changes underneath it.
In the case that shaped this page, weight was stable for a year while roughly a third of skeletal muscle went. Nothing on the chart moved. Everything about what the person could do had.
What notices it is not the scale. It is the stairs, the chair, the shopping bag, the walk that used to be nothing. You will know before any measurement does.
GRADE A Simultaneous muscle loss and fat gain with stable weight is a well-described pattern with a name — sarcopenic obesity — and it carries risks beyond either part alone.
“My weight is the same but I am much weaker. Can we measure muscle rather than weight?”
Statins are not the only drugs that can do this, and some combinations matter more than either drug alone — certain antibiotics, some antifungals, and a number of heart medicines can raise statin levels considerably.
The timing is the evidence you hold and nobody else does. Whether it began in the fortnight after a new prescription, or after a dose was increased, or after something was added, is exactly the sort of thing that never makes it into a seven-minute appointment unless you bring it.
Write the dates down before you go. Not a symptom diary — two lines. When the medicine changed, and when you first noticed. That single pairing has redirected more consultations than any test on this page.
GRADE A Interactions that raise statin blood levels, and the resulting increase in muscle risk, are established and on the labelling.
“This started about two weeks after that medicine changed. Is there an interaction between them?”
Several chemotherapy regimens cause muscle loss in their own right, and the relationship runs both ways: low muscle mass is associated with more toxicity and poorer tolerance of treatment, and the treatment causes more muscle loss.
Which means the two problems on this page arrive together, and each makes the other harder to see. Muscle is being lost from two directions at once, and both of the numbers that might have warned somebody — CK and eGFR — are being pushed in the reassuring direction by the very thing that should be alarming.
GRADE B The individual relationships are established. The compounding as described here is carried from this project’s own work.
“Between the chemotherapy and the statin, is anybody tracking my muscle mass rather than my weight?”
Read them in any order and you end up where you started. That is not a weakness in the explanation. It is what the thing is.
We would rather not use that phrase. We are using it because it is accurate, and because pretending otherwise would not help you.
Nothing on this page requires anyone to have made a mistake. A statin at a sensible dose, a kidney number read the usual way, a CK inside the reference range, muscle loss that looked like ordinary ageing — each decision defensible on its own. The harm lives in the combination, and the combination is nobody’s assigned responsibility. You are the only person who sees all of it, because you are the only one who is at every appointment.
So, politely and practically:
And the boundary, plainly. None of this is a reason to stop a medicine, change a dose, or decline treatment. This page exists to get a question asked, not to answer it. The answer belongs to somebody who can examine you and see your whole record.
This page is about a possible cost. So you should know what you are weighing it against.
Have you already had a heart attack or a stroke?
If you have, the statin is doing a lot of work. Almost nobody argues about that.
If you have not, it is there to stop a first one. The benefit is real. It is also much smaller. Same drug, same advice at the counter — two very different situations.
Ask for the plain number.
“Cuts your risk by a third” and “takes it from 3 in 100 down to 2 in 100” can be the same result.
The first sounds much bigger. The second is the one you can actually weigh. Both are true. Ask for the second one.
Know what it was compared with.
Statins were tested against a dummy pill, and against each other. Some other approaches were never tested against them. Nobody paid for those trials.
So “the best we have” means the best of what got tested.
GRADE A The first two are standard. Any doctor will know them. Most will be glad you asked.
GRADE U The third is about a gap in the research, not a finding in it. A test nobody ran tells you nothing either way. We mention it because a gap nobody mentions gets mistaken for a settled answer.
“Am I taking this to stop a first heart attack, or a second one? And what does it do for someone like me, in plain numbers?”
That is not a challenge to the prescription. It is the question the prescription was based on, said out loud.
When did you first notice? Not when a test showed something — when you noticed. And what were you doing at the time.
Which way is it going? Better, worse, or level, over weeks rather than days.
What is it actually like? Aching, weakness, cramp, stiffness, tenderness to touch — these point in different directions.
Where is it? Thighs and shoulders behave differently from hands and feet, and the pattern matters more than the severity.
What changed around the same time? Any new medicine, any dose increase, any illness — even if it seems unrelated.
What have you tried, and what happened? Including anything you stopped, and whether stopping helped.
What have you stopped doing? The stairs, the garden, the walk. This is the question that says the most and gets asked the least.
What worries you most about it? Not the medical question — the real one.
What is Grade A here. Five things, each established on its own:
What is Grade B: the loop as this page assembles it. Every link is established on its own. Presenting them as one self-reinforcing circle is our reading, and we are saying so rather than letting it borrow the credibility of its parts.
Why this page exists.
There is a real case behind it. A statin broke muscle down. The CK came back above 25,000.
About a third of her skeletal muscle was lost. Her weight did not change at all, so nothing on the chart moved.
Afterwards, that same muscle loss made her kidney number look better than it was. Doses were set from it.
Every one of those facts was known and written down beforehand. Not one was a surprise.
That is why this room is here. And it is why it is written for the person in the chair, not for the file.